§ Funding Round
Neurophth Therapeutics raised $60M Series C venture round, led by CMG-SDIC Capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
CMB International | — | — |
CMG-SDIC CapitalLEAD | — | — |
Hongshan Capital Group (Sequoia Capital China)LEAD | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$217M
Top Valuation
-
Neurophth Therapeutics raised $60M in a Series C round.
The round was announced on 11/23/21.
The round was led by CMG-SDIC Capital, Hongshan Capital Group (Sequoia Capital China).
